BIOMERIEUX (EPA:BIM) | WebDisclosure

Basculer en Français

9480	Companies
185559	Keywords
117951	Articles
99390	Press releases

Home
Companies
BIOMERIEUX

REGULATED PRESS RELEASE

published on 10/30/2024 at 07:01, 1 year 1 month ago

bioMérieux – Third-Quarter 2024 Business Review
bioMérieux reports strong +10.3% organic sales growth, reaching €2,871m in the first nine months of 2024, driven by growth drivers like GO•28 strategic plan and BIOFIRE® respiratory panels. Q3 2024 shows an +11% organic sales growth with confirmation of 2024 full-year revised guidance. CEO Pierre Boulud expresses confidence in achieving targets

BioMérieux Organic Sales Growth 2024 Guidance GO•28 Strategic Plan BIOFIRE Respiratory Panels
REGULATED PRESS RELEASE

published on 10/30/2024 at 07:01, 1 year 1 month ago

bioMérieux – Information financière du 3ème trimestre 2024
bioMérieux annonce une croissance organique de +10,3% au 3ème trimestre 2024, avec une dynamique forte dans les segments cliniques et industriels, confirmant les objectifs annuels. Le Directeur Général souligne la performance dynamique et l'engagement des collaborateurs

BioMérieux Objectifs Annuels Croissance Organique 3ème Trimestre 2024 Segments Cliniques
BRIEF

published on 10/15/2024 at 07:06, 1 year 1 month ago

BioMérieux Receives CE-Marking for VIDAS® Vitamin B12 Test

BioMérieux Diagnostics Vitamin B12 CE-marking VIDAS®
BRIEF

published on 10/15/2024 at 07:06, 1 year 1 month ago

BioMérieux reçoit le marquage CE pour le test VIDAS® VITAMIN B12 TOTAL

BioMérieux Diagnostic In Vitro Vitamine B12 Test VIDAS® Anémie
REGULATED PRESS RELEASE

published on 10/15/2024 at 07:01, 1 year 1 month ago

bioMérieux receives CE-marking for VIDAS® VITAMIN B12 TOTAL, a blood test to measure total Vitamin B12 concentration
bioMerieux announces CE-marking for VIDAS Vitamin B12 Total, an automated blood test to measure total B12 concentration in serum or plasma, aiding in the assessment of B12 status and optimizing patient care

BioMérieux CE-marking VIDAS Vitamin B12 Total Blood Test
REGULATED PRESS RELEASE

published on 10/15/2024 at 07:01, 1 year 1 month ago

bioMérieux obtient le marquage CE du test sanguin VIDAS® VITAMIN B12 TOTAL mesurant la concentration totale de vitamine B12
bioMérieux obtient le marquage CE pour le test sanguin VIDAS VITAMIN B12 TOTAL mesurant la concentration totale de vitamine B12, renforçant leur gamme d'immunoessais

BioMérieux Marquage CE VIDAS Vitamine B12 Test Sanguin
BRIEF

published on 10/08/2024 at 10:45, 1 year 1 month ago

Actualisation du nombre d'actions et de droits de vote de bioMérieux

Marché Financier Droits De Vote BioMérieux Actions Transparence
BRIEF

published on 10/08/2024 at 10:45, 1 year 1 month ago

Update of the number of shares and voting rights of bioMérieux

Voting Rights BioMérieux Actions Transparency Financial Market
REGULATED PRESS RELEASE

published on 10/08/2024 at 10:40, 1 year 1 month ago

Septembre 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
bioMérieux annonce les informations mensuelles relatives au nombre total de droits de vote et d'actions. Nombre de droits de vote théoriques : 191 139 182

Autorité Des Marchés Financiers Droits De Vote BioMérieux Actions Informations Mensuelles
REGULATED PRESS RELEASE

published on 09/05/2024 at 07:01, 1 year 3 months ago

bioMérieux – First-Half 2024 Results

Accesswire

Published on 12/05/2025 at 21:45, 1 hour 10 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 1 hour 25 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 1 hour 35 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 55 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 2 hours 30 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 39 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 42 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 3 hours 56 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 4 hours 28 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 4 hours 39 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 17:18, 5 hours 37 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 5 hours 37 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 7 hours 44 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 7 hours 44 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 56 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE